Immunic, inc. to participate in scientific, investor and industry conferences in april

New york, april 13, 2021 /prnewswire/ -- immunic, inc. (nasdaq: imux), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced participation in the following scientific, investor and industry conferences in april: april 17-22: 2021 virtual american academy of neurology (aan) annual meeting. robert j.
IMUX Ratings Summary
IMUX Quant Ranking